New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
09:25 EDTMYL, MYL, ATI, ATI, IIVI, IIVI, KOP, KOP, ANSS, ANSS, FSTR, FSTR, BBOX, BBOX, KMT, KMT, STBA, STBA, CCC, CCC, EQT, EQT, WCC, WCCCFA Society of Pittsburgh to hold a conference
2014 INVESTPennsylvania Equity Conference to be held in Pittsburgh on May 29 with webcasted company presentations to begin at 9:25 am; not all company presentations may be webcasted. Webcast Link
News For MYL;EQT;CCC;STBA;KMT;BBOX;FSTR;ANSS;KOP;IIVI;ATI;WCC From The Last 14 Days
Check below for free stories on MYL;EQT;CCC;STBA;KMT;BBOX;FSTR;ANSS;KOP;IIVI;ATI;WCC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 16, 2014
09:59 EDTANSSOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: ACI Worldwide (ACIW) initiated with a Neutral at Sterne Agee... ADP (ADP) initiated with a Market Perform at Bernstein... ANSYS (ANSS) initiated with a Sector Perform at RBC Capital... Accenture (ACN) initiated with a Market Perform at Bernstein... Blackhawk (HAWK) initiated with a Neutral at Sterne Agee... Coca-Cola (KO) initiated with a Market Perform at Cowen... Cognizant (CTSH) initiated with an Outperform at Bernstein... Constellation Brands (STZ) initiated with a Market Perform at Cowen... Dr Pepper Snapple (DPS) initiated with a Market Perform at Cowen... GenCorp (GY) initiated with a Hold at KeyBanc... Global Payments (GPN) initiated with a Neutral at Piper Jaffray... GoPro (GPRO) initiated with a Buy at Cleveland Research... Green Dot (GDOT) initiated with a Neutral at Sterne Agee... Lionsgate (LGF) initiated with a Buy at ISI Group... MEDNAX (MD) initiated with a Neutral at SunTrust... MasterCard (MA) initiated with a Buy at Sterne Agee... Molson Coors (TAP) initiated with an Outperform at Cowen... Monster Beverage (MNST) initiated with a Market Perform at Cowen... NetSuite (N) initiated with an Outperform at RBC Capital... Oracle (ORCL) assumed with a Sector Perform at RBC Capital... PepsiCo (PEP) initiated with an Outperform at Cowen... SAP (SAP) initiated with a Sector Perform at RBC Capital... Teekay (TK) initiated with a Hold at Deutsche Bank... Tesla (TSLA) initiated with a Buy at ISI Group... Visa (V) initiated with a Buy at Sterne Agee... Western Union (WU) initiated with a Neutral at Sterne Agee... Workday (WDAY) initiated with an Outperform at RBC Capital... Yelp (YELP) initiated with a Neutral at RW Baird... Zillow (Z) initiated with an Overweight at Stephens... zulily (ZU) initiated with an Outperform at RW Baird.
09:45 EDTCCCCalgon Carbon unit signs MOU with Keppel Shipyard, SEAQUEST
Hyde Marine, a wholly owned subsidiary of Calgon Carbon Corporation, has established a Memorandum of Understanding with Singapore-based Keppel Shipyard and SEAQUEST Marine Systems PTE, Ltd., for installation of the chemical free Hyde GUARDIAN Gold Ballast Water Treatment System in international markets. Under the MOU, Keppel Shipyard will be able to carry out retrofit installations of Hyde GUARDIAN Gold BWTS at its Singapore shipyard. Such a partnership will position Hyde Marine for the anticipated increase in the Asian retrofit market after the maritime industry is required to comply with international ballast water treatment regulations.
07:33 EDTMYLMylan initiates Phase III clinical trials for Advair Diskus and Lantus
Mylan (MYL) announced it is initiating Phase III clinical trials for its generic version of GlaxoSmithKline's (GKS) Advair Diskus and its insulin analog to Sanofi's (SNY) Lantus. In October Mylan will commence a Phase III clinical trial to evaluate the equivalence of its product to Advair Diskus when administered by inhalation in adult asthma patients.
September 15, 2014
16:39 EDTANSSANSYS initiated with a Sector Perform at RBC Capital
Target $90.
08:38 EDTKMTKennametal reports consolidated orders for 3 months end August up 16%
Subscribe for More Information
06:34 EDTMYLMylan signs agreement with Gilead
Mylan (MYL) announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead Sciences (GILD), under which Mylan has been licensed the non-exclusive rights to manufacture and distribute sofosbuvir and the investigational single tablet regimen of ledipasvir/sofosbuvir in 91 developing countries. Sofosbuvir is marketed by Gilead under the brand name Sovaldi. The countries within the agreement account for more than 100M people living with hepatitis C globally representing 54% of the total global infected population. Under the licensing agreement, Mylan will receive a technology transfer enabling the company to manufacture low-cost versions of the medicines for developing markets.
September 11, 2014
10:00 EDTWCCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:27 EDTCCCCalgon Carbon awarded 10-year contract for reactivation services by Palmdale
Calgon Carbon Corporation announced that the company and Palmdale Water District, have signed a 10-year contract under which Calgon Carbon will provide reactivation services to treat the Districtís drinking water. The value of the contract will depend upon the amount of spent carbon that is reactivated annually, which is expected to be 1 million pounds.
06:32 EDTWCCWESCO upgraded to Overweight from Neutral at JPMorgan
Subscribe for More Information
06:09 EDTWCCWESCO upgraded to Overweight from Neutral at JPMorgan
Subscribe for More Information
September 10, 2014
07:49 EDTKMTLongbow to hold a conference
Subscribe for More Information
07:03 EDTFSTRDA Davidson to hold a conference
Subscribe for More Information
07:02 EDTMYLMylan to acquire U.S. rights to Arixtra injection from Aspen
Mylan's subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S. commercialization, marketing and intellectual property rights relating to Arixtra Injection and the authorized generic of Arixtra from Aspen Global Incorporated. Arixtra is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism in patients undergoing hip fracture surgery. Mylan already is selling Arixtra in the U.S. through an interim distribution arrangement with Aspen and Apotex is currently selling the AG of Arixtra, which will be transitioning to Mylan Institutional by year end.
September 9, 2014
07:10 EDTATIGabelli to hold a conference
Subscribe for More Information
06:42 EDTMYLLew expects to make decision on combating inversion deals soon, NY Times reports
Subscribe for More Information
September 8, 2014
11:05 EDTMYLOptions with increasing implied volatility
Options with increasing implied volatility: NPSP GILD VNET AVNR GTAT YHOO RHT VRTX SDRL COV MYL
10:04 EDTMYLMylan calls active on activist investor speculation
Subscribe for More Information
09:57 EDTMYLRumor: Mylan moves up on activist investor speculation
Subscribe for More Information
09:27 EDTMYLLeerink biotech analyst holds a luncheon meeting with a conference call
Biotech Analyst Schwartz provides an update on key trends and controversies for marketed MS therapies and discusses new data presented at ACTRIMS-ECTRIMS at a Luncheon Meeting with an Analyst/Industry conference call to be held in Boston on September 11 at 12:15 pm.
07:03 EDTMYLMylan annoucnes court grants summary judgment in favor of company
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use